Home » today » Health » Covid-19: why is the Medicines Safety Agency withdrawing the Previdspray nasal spray from the market?

Covid-19: why is the Medicines Safety Agency withdrawing the Previdspray nasal spray from the market?

The virucidal nasal spray Previdspray, supposed to protect against Covid-19, must be removed from pharmacies and all points of sale in France, the French Medicines Agency (ANSM) decided on Friday May 6. People who still have the product are invited to throw it away.

The National Medicines Safety Agency (ANSM) has stopped the marketing of the virucidal nasal spray Previdspray against Covid-19. Its manufacturer, Clers Medical, being registered in Belgium, the Belgian Federal Agency for Medicines and Health Products (FAMHP) was seized to investigate this product.

covid by The Independent newspaper on Scribd

“According to the FAMHP, the product’s technical documents do not present sufficient clinical evidence to justify use against the SARS-CoV-2 virus responsible for Covid-19 disease”says the ANSM in a press release.

Consequently, the marketing of this product in pharmacies or any other place in France is stopped. In accordance with the FAMHP’s request, Clers Medical is required to withdraw the batches of these devices”declares the ANSM.

According to the agency, the clinical data are not sufficient to justify use against Covid-19. People who still have the virucidal nasal spray Previdspray are invited to throw it away.

The ANSM requests the withdrawal of the Previdspray medical device in France, with an associated request for the immediate quarantine of the products concerned.

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.